 ⫽ 0 %);
nonsignificant reduction in the risk of non-fatal myocardial
infarction (RR 0.43 [0.17-1.11]; CI 0.16, 0.96; I2 ⫽ 0%);
and nonsignificant increase in the risk of any stroke (RR
1.29 [0.37-2.26]; CI 0.82,